MEF2D

From Wikipedia, the free encyclopedia


MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D)
PDB rendering based on 1c7u.
Available structures: 1c7u, 1egw
Identifiers
Symbol(s) MEF2D; DKFZp686I1536
External IDs OMIM: 600663 MGI99533 HomoloGene4327
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 4209 17261
Ensembl ENSG00000116604 ENSMUSG00000001419
Uniprot Q14814 Q3URR2
Refseq NM_005920 (mRNA)
NP_005911 (protein)
XM_987375 (mRNA)
XP_992469 (protein)
Location Chr 1: 154.7 - 154.74 Mb Chr 3: 88.23 - 88.25 Mb
Pubmed search [1] [2]

MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D), also known as MEF2D, is a human gene.[1]


Contents

[edit] See also

[edit] References

[edit] Further reading

  • Breitbart RE, Liang CS, Smoot LB, et al. (1994). "A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage.". Development 118 (4): 1095–106. PMID 8269842. 
  • Hobson GM, Krahe R, Garcia E, et al. (1996). "Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23.". Genomics 29 (3): 704–11. doi:10.1006/geno.1995.9007. PMID 8575763. 
  • Ornatsky OI, McDermott JC (1996). "MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells.". J. Biol. Chem. 271 (40): 24927–33. PMID 8798771. 
  • Yang CC, Ornatsky OI, McDermott JC, et al. (1998). "Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.". Nucleic Acids Res. 26 (20): 4771–7. PMID 9753748. 
  • Zhao M, New L, Kravchenko VV, et al. (1999). "Regulation of the MEF2 family of transcription factors by p38.". Mol. Cell. Biol. 19 (1): 21–30. PMID 9858528. 
  • Wang AH, Bertos NR, Vezmar M, et al. (1999). "HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.". Mol. Cell. Biol. 19 (11): 7816–27. PMID 10523670. 
  • Lu J, McKinsey TA, Nicol RL, Olson EN (2000). "Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.". Proc. Natl. Acad. Sci. U.S.A. 97 (8): 4070–5. doi:10.1073/pnas.080064097. PMID 10737771. 
  • Kato Y, Zhao M, Morikawa A, et al. (2000). "Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.". J. Biol. Chem. 275 (24): 18534–40. doi:10.1074/jbc.M001573200. PMID 10849446. 
  • Youn HD, Chatila TA, Liu JO (2000). "Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis.". EMBO J. 19 (16): 4323–31. doi:10.1093/emboj/19.16.4323. PMID 10944115. 
  • Slepak TI, Webster KA, Zang J, et al. (2001). "Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D.". J. Biol. Chem. 276 (10): 7575–85. doi:10.1074/jbc.M004625200. PMID 11096067. 
  • Choi SJ, Park SY, Han TH (2001). "14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.". Nucleic Acids Res. 29 (13): 2836–42. PMID 11433030. 
  • Okamoto S, Li Z, Ju C, et al. (2002). "Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.". Proc. Natl. Acad. Sci. U.S.A. 99 (6): 3974–9. doi:10.1073/pnas.022036399. PMID 11904443. 
  • Park SY, Shin HM, Han TH (2002). "Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter.". Mol. Immunol. 39 (1-2): 25–30. PMID 12213324. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Linseman DA, Bartley CM, Le SS, et al. (2003). "Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival.". J. Biol. Chem. 278 (42): 41472–81. doi:10.1074/jbc.M307245200. PMID 12896970. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039. 
  • Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins.". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMID 15302935. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Grégoire S, Yang XJ (2005). "Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.". Mol. Cell. Biol. 25 (6): 2273–87. doi:10.1128/MCB.25.6.2273-2287.2005. PMID 15743823. 
  • Prima V, Gore L, Caires A, et al. (2005). "Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.". Leukemia 19 (5): 806–13. doi:10.1038/sj.leu.2403684. PMID 15744350. 

[edit] External links